• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Feb. 4

    MO SCI Acquires Assets of 3M’s Advanced Materials Business

    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Paragon Medical

    Forefront Medical Technology

    JBC Technologies

    Providence Enterprise USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    Paragon Medical

    Forefront Medical Technology

    JBC Technologies

    Providence Enterprise USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Tips for Protecting Intellectual Property to Secure Funding

    This column provides tips on how to ensure a medtech company’s other valuable intellectual property is ready for due diligence.

    Tips for Protecting Intellectual Property to Secure Funding
    Roman Fayerberg, David J. Dykeman, Todd Basile, Registered Patent Attorneys, Greenberg Traurig LLP07.22.21
    Intellectual property due diligence is a critical step of any acquisition or investment process. In our previous MPO column, we provided tips for preparing for and passing patent due diligence. In addition to patents, medtech companies utilize other types of intellectual property, such as software, data protection, and trade secrets to distinguish themselves from the competition. This column provides tips on how to ensure a medtech company’s other valuable intellectual property is ready for due diligence.

    Software
    As medical diagnoses and treatments evolve, software is moving to the forefront of the medtech industry. The use of augmented reality to assist in surgery, the use of artificial intelligence in diagnostics, and robotic surgeries are becoming more commonplace. For companies in this space, software is an important asset, and the investors will want to make sure proprietary software is adequately protected.

    One of the most scrutinized issues in software due diligence is ownership. Companies increasingly outsource development to contractors and adopt customer suggestions for new features and functionality. It may seem natural that the company would own the resulting code and intellectual property, but disputes often arise if ownership rights are not clearly documented. Accordingly, agreements with employees, developers, customers, and end users should each include assignment provisions conveying any ownership rights these parties may have to the company.

    Investors also frequently explore how open source software (OSS) and third-party software and libraries (collectively “third-party components”) are used in a company’s proprietary software. It is important for companies to ensure such use complies with the licensing terms and conditions associated with each third-party component, otherwise significant issues could arise. For example, some OSS is subject to copyleft licensing terms that may force software companies to publish their source code and/or provide their software to the public for free. Removing OSS often involves costly redesigns to avoid potential copyright infringement going forward. Companies should track their use of OSS and third-party software and ensure its agreements require developers to adhere to the company’s policies and identify all such software components included in their deliverables.

    Another issue is the protection of the proprietary software. In light of the U.S. Supreme Court’s decision in Alice Corp. vs. CLS Bank, it has become more difficult to obtain patent protection for software.

    Nevertheless, working with a knowledgeable patent counsel can assist companies to secure patents for its software innovations. To supplement patents, companies should also consider relying on copyrights to protect software code and proprietary libraries or databases.

    Data
    Medtech companies often derive valuable insights about their products using data collected by connected medical devices. As such, a company’s data can be one of its most valuable intellectual property assets and investors will want to confirm the data is adequately protected.

    As with software, one of the most important considerations with respect to proprietary data is ownership. Companies should update their terms and conditions to ensure the company owns all such data, or at least has patients’ permission to use information collected for the purposes envisioned by the company. Because data is often collected from medical devices and may include personal identifiable information of patients, medtech companies should also ensure their software meets data security and privacy guidelines. Non-compliance with privacy regulations such as HIPAA and European General Data Protection Regulation (GDPR) may result in civil or even criminal liabilities, and could become an issue in due diligence.

    Trade Secrets
    Trade secrets are another valuable asset reviewed during diligence by medtech investors. A medtech company’s success is often attributable to its confidential information and know-how. Accordingly, investors want to see companies implementing strong safeguards and policies to keep valuable information proprietary to the company.

    At a minimum, companies should ensure that all employees, contractors, visitors, and potential partners sign written non-disclosure agreements (NDA). A well-drafted NDA will not only require the recipient of confidential information to avoid disclosure to third parties, but also will constrain the recipient’s use of the confidential information to a limited purpose (e.g., evaluating the compatibility of the company’s technology with the recipient’s product). This tends to make recipients more mindful of protecting the company’s information.

    Even with such safeguards in place, companies should also implement procedures to restrict access to its trade secrets on a “need-to-know” basis. For example, companies may configure their IT systems so certain technical information is accessible only to engineers or scientists that need such information to perform their job and is not accessible to other departments. Likewise, software-related trade secrets can be protected by providing customers and authorized third parties with access only to application programming interfaces and executable files, and no access to the underlying source code, libraries, and databases where a company’s “secret sauce” typically resides. Finally, if a situation arises when the trade secrets need to be disclosed, for example, as part of a joint venture, the companies should have procedures ensuring that trade secrets are disclosed only to the extent absolutely necessary and only after executing a strong NDA.

    IP Licenses
    Many medtech companies utilize third-party intellectual property in their everyday business. Typical licensed intellectual property includes patents and software, but all types of intellectual property can be licensed.

    One issue that typically arises in connection with IP licenses is the scope of rights granted by the license. For example, a licensee should make sure the licensed field of use and territory cover not only the current, but also contemplated, uses and markets. Other important provisions that typically determine the value of the license are the term of the license, ability of licensee to freely sublicense or assign the license, financial obligations (royalty rates and milestone payments) required by the license, ownership of improvements, and the ability of licensor to terminate the license. A medtech company seeking investment should review its IP licenses and address these issues before they are raised by investors.

    Conclusion
    To prepare for due diligence, a medtech company should periodically audit its intellectual property assets to ensure that it (1) fully owns its proprietary software, that such software is protected and is in compliance with privacy and cybersecurity laws and practices, (2) has a trade secret policy, and (3) has IP licenses providing the necessary scope of rights that will not be impacted by the investment or acquisition. Finding and fixing potential IP issues ahead of time should help investors gain confidence in the target company and expedite the due diligence process. 


    Roman Fayerberg is a registered patent attorney with more than 15 years of experience in patent and IP law. He advises clients on procurement and enforcement of IP rights, including domestic and international patents, with the focus on robotics, medtech and life science technologies. He can be reached at fayerbergr@gtlaw.com.

    David J. Dykeman is a registered patent attorney with nearly 25 years of experience in patent and IP law and is co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group. Dykeman’s practice focuses on securing worldwide intellectual property protection and related business strategy for high-tech clients, with particular experience in medical devices, robotics, wearables, life sciences, and information technology. He can be reached at dykemand@gtlaw.com.

    Todd Basile is a registered patent attorney with more than 15 years of combined experience in the tech and legal industries. He helps technology companies protect and commercialize their innovations and brands across various industries including medtech, robotics, and software. He also represents technology investors in M&A deals, negotiates technology transactions, and assists clients in navigating IP disputes. He can be reached at basilet@gtlaw.com.
      Loading, Please Wait..

      Trending
      • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
      • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
      • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
      • The Future Of Biomedical Engineering Advancements
      • A New Approach To Post-Market Surveillance
      Breaking News
      • MPO's Most-Read Stories This Week—Feb. 4
      • MO SCI Acquires Assets of 3M’s Advanced Materials Business
      • Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
      • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
      • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
      View Breaking News >
      CURRENT ISSUE

      January/February 2023

      • Struggling Suppliers in Electronics Manufacturing Services (EMS)
      • Machining & Laser Processing Have Huge Parts to Play
      • Medtech R&D Teams Must Be Creative & Resilient to Survive
      • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
      • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Elects New Board Officers for 2023
      Aspire Hires Darrec Jones as VP of Business Development
      Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
      Coatings World

      Latest Breaking News From Coatings World

      PPG Completes COLORFUL COMMUNITIES Project in Denmark
      10 Partners of the Automotive Industry Form JV, Cofinity-X
      BASF Recognized as Top Company for Supplier Diversity
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—Feb. 4
      MO SCI Acquires Assets of 3M’s Advanced Materials Business
      Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Lilly 4Q Revenues Down 9% to $7.3B
      Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
      Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Pacifica Introduces Glow Baby Skincare Line
      Kohl’s Names Tom Kingsbury as Chief Executive Officer
      Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
      Happi

      Latest Breaking News From Happi

      Glow Balms and Slugging are Top Skincare Trends: Spate
      Curl Care Sales Jump as Consumers Transition to Natural Hairstyles
      Amyris & Tia Mowry’s Haircare Launch, New Product Awards in Beauty and Home Care
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Pigments, Inkjet Ink Market Reports Top This Week’s Stories
      Roland DGA Announces Key Changes to Leadership Team
      Ball Reports 2022 Results
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Brandywine names new president, Brook + Whittle grows and more
      MM Packaging adds first Nilpeter press for Dublin site
      Polytag develops new UV tag reading technology
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: K-C Requests Huggies-Related Lawsuit to be Thrown Out, WPT Makes Investment & More
      What You’re Reading on Nonwovens-Industry.com
      Kimberly-Clark Supports Period Poverty Initiative in Australia
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most-Read Stories This Week—Feb. 4
      Toetal Solutions Secures $1.8 Million in New Financing
      Adrian Tyndall Joins Axogen's Board of Directors
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: CES 2023, ams OSRAM and Celanese Top This Week’s Stories
      Zebra Provides East West Shrine Bowl with RFID Tracking Technology
      AAAS Elects Three ORNL Scientists as Fellows

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login